Chemung Canal Trust Company Raised Pfizer (PFE) Holding By $386,398; Equinor Asa (EQNR) Shorts Lowered By 5.85%

Pfizer Inc. (NYSE:PFE) Logo

Chemung Canal Trust Company increased Pfizer (PFE) stake by 3.99% reported in 2018Q4 SEC filing. Chemung Canal Trust Company acquired 8,986 shares as Pfizer (PFE)’s stock declined 4.08%. The Chemung Canal Trust Company holds 234,280 shares with $10.23 million value, up from 225,294 last quarter. Pfizer now has $228.68B valuation. The stock decreased 1.95% or $0.82 during the last trading session, reaching $41.19. About 27.33 million shares traded or 3.31% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since March 15, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 14/03/2018 – #AACR18 Precision oncology session; 23/05/2018 – Pfizer: FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients With Transthyretin Cardiomyopathy; 16/05/2018 – ASTRAZENECA IS SAID TO WEIGH SALE OF U.S. RIGHTS FOR CRESTOR; 23/03/2018 – INNATE PHARMA SA – PARTNER MEDIMMUNE EXPANDS COLORECTAL CANCER PATIENT COHORT IN ONGOING PHASE l TRIAL EVALUATING MONALIZUMAB IN COMBINATION WITH IMFINZI® (DURVALUMAB); 15/05/2018 – Rexahn Phase 2a Combination Study of RX-3117 and Abraxane in First-line Metastatic Pancreatic Cancer Patients Advances to Second Stage; 12/04/2018 – PFIZER INC – EARLY DATA FROM MINI-DYSTROPHIN GENE THERAPY STUDY TRIAL ARE EXPECTED IN FIRST HALF OF 2019; 23/03/2018 – PFIZER ALTERNATIVES INCLUDE A SPIN-OFF, SALE; 15/05/2018 – PFIZER’S BIOSIMILAR RETACRIT® (EPOETIN ALFA-EPBX) APPROVED BY U; 29/03/2018 – PFIZER: POSITIVE TOPLINE RESULTS FROM PHASE 3 ATTR-ACT STUDY OF; 08/03/2018 – FDA panel backs Pfizer’s Xeljanz as bowel disease treatment

Equinor Asa (NYSE:EQNR) had a decrease of 5.85% in short interest. EQNR’s SI was 4.50M shares in March as released by FINRA. Its down 5.85% from 4.78M shares previously. With 1.31 million avg volume, 3 days are for Equinor Asa (NYSE:EQNR)’s short sellers to cover EQNR’s short positions. The SI to Equinor Asa’s float is 0.42%. The stock increased 0.35% or $0.08 during the last trading session, reaching $22.62. About 458,920 shares traded. Equinor ASA (NYSE:EQNR) has declined 0.75% since March 15, 2018 and is downtrending. It has underperformed by 5.12% the S&P500. Some Historical EQNR News: 25/05/2018 – EQUINOR EXERCISES AF OPTION FOR HVAC FOR SVERDRUP PHASE 2; 25/05/2018 – EQUINOR ASA EQNR.OL – SCHEDULED TO START AT TURN OF YEAR 2018/2019, DRILLING OF THREE WELLS WILL TAKE AROUND ONE YEAR; 30/05/2018 – AZERI OIL COMPANY SOCAR, NORWAY’S EQUINOR (FORMERLY STATOIL) SIGN PSA AGREEMENT ON DEVELOPING ASHRAFI AND AYPARA FIELDS IN CASPIAN SEA; 23/05/2018 – EQUINOR ASA EQNR.OL – EQUINOR IS PLEASED TO HAVE BEEN AWARDED 9 NEW LICENCES IN 30TH OFFSHORE LICENSING ROUND, 8 AS OPERATOR, AS ANNOUNCED BY OIL AND GAS AUTHORITY (OGA) TODAY; 25/05/2018 – STATOIL: NEW DRILLING CONTRACT TO DEEPSEA ATLANTIC – NEW DRILLING CONTRACT TO DEEPSEA ATLANTIC – EQUINOR.COM; 23/05/2018 – Statoil: Equinor ASA: Notifiable trading; 29/05/2018 – REG-Recommendation from Equinor’s nomination committee; 29/05/2018 – EQUINOR ASA EQNR.OL – RECOMMENDS A RE-ELECTION OF JON ERIK REINHARDSEN AS CHAIR AND ROY FRANKLIN AS DEPUTY CHAIR OF BOARD; 24/05/2018 – EQUINOR SAYS TROLL A PLATFORM SHUT ON THURSDAY UNTIL 1700 GMT; 25/05/2018 – Statoil: Equinor ASA: Announcement of dividend per share for the fourth quarter 2017 in NOK

Since January 30, 2019, it had 0 insider buys, and 1 sale for $1.81 million activity. LANKLER DOUGLAS M sold $1.81M worth of stock or 43,800 shares.

Investors sentiment decreased to 0.74 in Q4 2018. Its down 0.11, from 0.85 in 2018Q3. It turned negative, as 42 investors sold PFE shares while 792 reduced holdings. 141 funds opened positions while 477 raised stakes. 4.05 billion shares or 2.27% more from 3.96 billion shares in 2018Q3 were reported. Kentucky Retirement Insur Tru Fund holds 114,342 shares or 1.25% of its portfolio. 45,070 were reported by Element Cap Limited Liability. Northpointe Llc reported 114,236 shares. Insurance Co Tx, a Texas-based fund reported 488,492 shares. Marietta Investment Partners Lc reported 9,163 shares or 0.15% of all its holdings. 2.42M were accumulated by Northeast Consultants. Conning owns 1.67% invested in Pfizer Inc. (NYSE:PFE) for 1.12M shares. Brown Advisory Secs reported 0.73% of its portfolio in Pfizer Inc. (NYSE:PFE). Moreover, Oakworth has 1.32% invested in Pfizer Inc. (NYSE:PFE) for 133,140 shares. Jacobs And Company Ca owns 182,721 shares or 1.57% of their US portfolio. Meyer Handelman accumulated 1.46 million shares or 3.59% of the stock. North Point Port Managers Oh, Ohio-based fund reported 5,193 shares. Farr Miller Washington Ltd Liability Dc has 0.33% invested in Pfizer Inc. (NYSE:PFE). Investec Asset North America has invested 0.29% of its portfolio in Pfizer Inc. (NYSE:PFE). Markston International Limited Liability Com reported 169,607 shares.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer prices $5B debt offering – Seeking Alpha” on March 05, 2019, also Seekingalpha.com with their article: “FDA OKs Pfizer’s Herceptin biosimilar – Seeking Alpha” published on March 12, 2019, Investorplace.com published: “The Case Against Pfizer Stock and the Rest of the Industry – Investorplace.com” on March 15, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer in-licenses diabetes candidate from AnTolRx – Seeking Alpha” published on March 05, 2019 as well as Seekingalpha.com‘s news article titled: “Study links Pfizer’s Celebrex to heart valve problems – Seeking Alpha” with publication date: February 25, 2019.

Among 6 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Pfizer had 11 analyst reports since October 31, 2018 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) earned “Outperform” rating by Credit Suisse on Thursday, January 31. The stock of Pfizer Inc. (NYSE:PFE) earned “Neutral” rating by Credit Suisse on Wednesday, October 31. As per Tuesday, November 6, the company rating was maintained by Citigroup. On Monday, February 25 the stock rating was initiated by UBS with “Hold”. As per Tuesday, December 11, the company rating was downgraded by JP Morgan. Cantor Fitzgerald maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, February 19. Cantor Fitzgerald has “Buy” rating and $53 target. BMO Capital Markets downgraded Pfizer Inc. (NYSE:PFE) on Thursday, November 1 to “Market Perform” rating. On Wednesday, January 23 the stock rating was downgraded by UBS to “Neutral”. The stock of Pfizer Inc. (NYSE:PFE) earned “Outperform” rating by Argus Research on Thursday, January 31.

Chemung Canal Trust Company decreased Capital (NYSE:COF) stake by 19,534 shares to 5,634 valued at $426,000 in 2018Q4. It also reduced Apple (NASDAQ:AAPL) stake by 27,089 shares and now owns 29,798 shares. Sector Spdr (XLI) was reduced too.

More notable recent Equinor ASA (NYSE:EQNR) news were published by: Globenewswire.com which released: “Equinor files Form 20-F and presents annual and sustainability reports for 2018 – GlobeNewswire” on March 15, 2019, also Seekingalpha.com with their article: “Equinor Hikes Dividend To 4.5%, Remains Cheap – Seeking Alpha” published on February 16, 2019, Globenewswire.com published: “Equinor ASA: Ex dividend Oslo Stock Exchange:EQNR – GlobeNewswire” on February 19, 2019. More interesting news about Equinor ASA (NYSE:EQNR) were released by: Seekingalpha.com and their article: “Equinor: Versatile Portfolio And Capital Discipline – Seeking Alpha” published on February 20, 2019 as well as Seekingalpha.com‘s news article titled: “Move by Norway’s $1T wealth fund to cut oil stocks excludes Shell, BP, others – Seeking Alpha” with publication date: March 08, 2019.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart